Mateo Krzypow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mateo Krzypow has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Cottignies-Calamarte
Université Paris Cité, Antiviral Activities of Antibodies Group
1 shared publication Olivier Schwartz
Antiviral Activities of Antibodies Group, Virus and Immunity Unit, Département de Virologie, Institut Pasteur
1 shared publication- Timothée Bruel
Université Paris Cité, Antiviral Activities of Antibodies Group
1 shared publication
Latest Publications
- Open Access
- 24 March 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (3) , e0214125
Impact of cellular proteases on the function of antiviral antibodies
Viruses evade antibodies through many mechanisms. While mutation remains the predominant pathway, host proteases can be hijacked upon viral infections and decrease antibody-mediated clearance. Proteolysis can degrade or shed viral antigens to create soluble decoys, induce conformational changes that reduce neutralization, and cleave Fc receptors and complement proteins, hindering Fc-effector antibody functions. This review synthesizes evidence on the interplay between viruses and host proteases to evade antiviral activities of antibodies.
- 24 March 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (3) , e0214125
Open AccessImpact of cellular proteases on the function of antiviral antibodies
Viruses evade antibodies through many mechanisms. While mutation remains the predominant pathway, host proteases can be hijacked upon viral infections and decrease antibody-mediated clearance. Proteolysis can degrade or shed viral antigens to create soluble decoys, induce conformational changes that reduce neutralization, and cleave Fc receptors and complement proteins, hindering Fc-effector antibody functions. This review synthesizes evidence on the interplay between viruses and host proteases to evade antiviral activities of antibodies.